HTN1
gene geneOn this page
Also known as HIS1
Summary
HTN1 (histatin 1, HGNC:5283) is a protein-coding gene on chromosome 4q13.3, encoding Histatin-1 (P15515). Histatins (Hsts) are cationic and histidine-rich secreted peptides mainly synthesized by saliva glands of humans and higher primates.
This gene encodes a member of the histatin family of small, histidine-rich, cationic proteins. They function as antimicrobial peptides and are important components of the innate immune system. Histatins are found in saliva and exhibit antibacterial, antifungal activities and function in wound healing.
Source: NCBI Gene 3346 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 7 total
- MANE Select transcript:
NM_002159
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:5283 |
| Approved symbol | HTN1 |
| Name | histatin 1 |
| Location | 4q13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HIS1 |
| Ensembl gene | ENSG00000126550 |
| Ensembl biotype | protein_coding |
| OMIM | 142701 |
| Entrez | 3346 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 2 protein_coding, 2 retained_intron
ENST00000246896, ENST00000503645, ENST00000506754, ENST00000511674
RefSeq mRNA: 2 — MANE Select: NM_002159
NM_001368990, NM_002159
CCDS: CCDS3534
Canonical transcript exons
ENST00000246896 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000865225 | 70055498 | 70055602 |
| ENSE00001024603 | 70054322 | 70054342 |
| ENSE00001171130 | 70058580 | 70058848 |
| ENSE00002449602 | 70054421 | 70054450 |
| ENSE00002483922 | 70050438 | 70050495 |
| ENSE00003576458 | 70053064 | 70053127 |
Expression profiles
Bgee: expression breadth broad, 41 present calls, max score 77.17.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 135.7463 / max 110055.0515, expressed in 30 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 47873 | 117.2553 | 27 |
| 47874 | 18.1819 | 11 |
| 47876 | 0.1972 | 4 |
| 47875 | 0.1119 | 3 |
Top tissues by expression
119 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.17 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 71.51 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 69.98 | gold quality |
| minor salivary gland | UBERON:0001830 | 67.04 | gold quality |
| placenta | UBERON:0001987 | 65.41 | gold quality |
| tonsil | UBERON:0002372 | 63.01 | gold quality |
| bone marrow | UBERON:0002371 | 52.24 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 44.00 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.46 | gold quality |
| sural nerve | UBERON:0015488 | 40.72 | gold quality |
| muscle tissue | UBERON:0002385 | 40.18 | gold quality |
| urinary bladder | UBERON:0001255 | 40.00 | gold quality |
| stromal cell of endometrium | CL:0002255 | 38.60 | gold quality |
| monocyte | CL:0000576 | 37.61 | gold quality |
| ganglionic eminence | UBERON:0004023 | 37.15 | gold quality |
| blood | UBERON:0000178 | 36.86 | gold quality |
| duodenum | UBERON:0002114 | 36.76 | gold quality |
| leukocyte | CL:0000738 | 36.71 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 35.41 | gold quality |
| apex of heart | UBERON:0002098 | 35.28 | gold quality |
| adrenal tissue | UBERON:0018303 | 35.08 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 33.96 | silver quality |
| left adrenal gland cortex | UBERON:0035825 | 33.84 | silver quality |
| adrenal gland | UBERON:0002369 | 33.17 | gold quality |
| primary visual cortex | UBERON:0002436 | 32.89 | gold quality |
| prefrontal cortex | UBERON:0000451 | 32.65 | gold quality |
| pancreas | UBERON:0001264 | 32.49 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.12 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 16)
- inhibits calcium phosphate precipitation (PMID:12060866)
- The results allowed locating sulfation on the last four tyrosines (Tyr 27, 30, 34, and 36). (PMID:17503797)
- histatin 1 (Hst1) and histatin 2 (Hst2) as major wound-closing factors in human saliva (PMID:18650243)
- These findings indicate that the regulation of the histatin gene expression may be intricate, and it seems to have a cell-type preference in the salivary gland cells. (PMID:19060311)
- We investigated interactions among and functions of histatin 1 and the other proteins that are present in saliva by using high-throughput mass spectrometric techniques. This led to the identification of 43 proteins able to interact with histatin 1. (PMID:23001880)
- Histatins are salivary proteins with antimicrobial activity. (PMID:2303595)
- Histatin-1 is specifically expressed in human lacrimal epithelium. (PMID:26824896)
- This study evaluated the effects of Hst1 on cellular barrier function. Hst1 counteracted the effects of epithelial-mesenchymal transition inducers on the outgrowth of oral cancer cell spheroids, suggesting that Hst1 affects processes that are implicated in cancer progression. (PMID:28522595)
- salivary histatin-1 is a novel proangiogenic factor that may contribute to oral wound healing (PMID:28751526)
- Histatin 1 is one of the most abundant histatins and recent reports show that it has a stimulating effect on cellular adherence, thereby suggesting a role in maintaining the quality of the epithelial barrier and stimulating mesenchymal-to-epithelial transition. (PMID:30138105)
- Presence of Histatin-1 in Human Tears and Association with Aqueous Deficient Dry Eye Diagnosis: A Preliminary Study. (PMID:31311993)
- Salivary Histatin 1 and 2 Are Targeted to Mitochondria and Endoplasmic Reticulum in Human Cells. (PMID:32225006)
- Human salivary histatin-1 (Hst1) promotes bone morphogenetic protein 2 (BMP2)-induced osteogenesis and angiogenesis. (PMID:32484586)
- Histatin-1 is an endogenous ligand of the sigma-2 receptor. (PMID:34233061)
- Association Between PD-L1 and Histatin1, 3 Expression in Advanced Head and Neck Squamous Cell Carcinoma. (PMID:35489730)
- GPCR/endocytosis/ERK signaling/S2R is involved in the regulation of the internalization, mitochondria-targeting and -activating properties of human salivary histatin 1. (PMID:35970844)
Cross-species orthologs
0 orthologs
Paralogs (2): STATH (ENSG00000126549), HTN3 (ENSG00000205649)
Protein
Protein identifiers
Histatin-1 — P15515 (reviewed: P15515)
Alternative names: Histidine-rich protein 1, Post-PB protein
All UniProt accessions (1): P15515
UniProt curated annotations — full annotation on UniProt →
Function. Histatins (Hsts) are cationic and histidine-rich secreted peptides mainly synthesized by saliva glands of humans and higher primates. Hsts are considered to be major precursors of the protective proteinaceous structure on tooth surfaces (enamel pellicle). Hsts can be divided into two major groups according to their biological functions: antimicrobial Hsts (e.g. Hst 5/HTN3) and cell-activating Hsts (e.g. Hst 1/HTN1 and Hst 2/HTN1). Hst 1/HTN1 and Hst 2/HTN1 act in different cell types (epithelium, fibroblasts and endothelium) in oral and non-oral mucosa. Hst 1 functions primarily as a wound healing factor by activating cell-surface and cell-cell adhesions, cell spreading and migration and it can also stimulate cellular metabolic activity. Hst 1 is internalized in host cells in a stereospecific and energy-dependent process, which is partially mediated by the G protein-coupled receptors (GPCR)-activated endocytosis. Internalized Hst 1 is targeted and released via early endosomes trafficking to the mitochondria, where it significantly enhances mitochondrial energy metabolism. At the mitochondria, Hst 1 increases mitochondria-ER contacts through binding with ER receptor TMEM97, which also stimulates metabolic activity and cell migration and may as well regulate calcium homeostasis of the cell. Also activates the ERK1/2 signaling pathway to promote cell migration, possibly upon interaction with GPRCs at the plasma membrane. Also triggers the RIN2/Rab5/Rac1 signaling cascade which activates endothelial cell adhesion, spreading and migration required for angiogenesis in the oral wound healing process, however the receptor that transduces Hst 1 signal has not yet been identified. Also displays antimicrobial functions against pathogenic yeast Candida albicans, although with less effectiveness than Hst 5. Hst 2 consists of the fragment sequence 12-28 of Hst 1. Similar to Hst 1, actively and stereospecifically internalized in host cells and targeted to the mitochondria and the ER and promotes cell metabolic activity. Also activates the ERK1/2 signaling pathway to promote cell migration and wound closure. In contrast with Hst 1, not able to promote cell-substrate and cell-cell adhesion.
Subunit / interactions. Interacts with TMEM97; the interaction induces Hst1-stimulating wound healing.
Subcellular location. Secreted. Mitochondrion. Endoplasmic reticulum membrane Secreted. Endoplasmic reticulum membrane.
Tissue specificity. Submandibular and parotid glands.
Post-translational modifications. Phosphorylated.
Domain organisation. The wound healing domain in C-terminus may promote cell migration and proliferation.
Miscellaneous. The recommended nomenclature of salivary peptides follows published guidelines. In agreement with the authors, it has been decided to indicate the boundaries of the peptides according to the positions within the precursor, and not in the mature protein, as has formerly been proposed. Histatin 1, histatin 3 and histatin 5 constitute more than 80% of the total histatin concentration.
Similarity. Belongs to the histatin/statherin family.
RefSeq proteins (2): NP_001355919, NP_002150* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR030773 | Histatin/statherin | Family |
UniProt features (9 total): modified residue 5, peptide 2, signal peptide 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P15515-F1 | 62.18 | 0.07 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (5): 21, 46, 49, 53, 55
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-6803157 | Antimicrobial peptides |
MSigDB gene sets: 155 (showing top):
GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM, FXR_IR1_Q6, GOBP_EPITHELIUM_DEVELOPMENT, REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_ANTIMICROBIAL_HUMORAL_RESPONSE, MYOGENIN_Q6, WWTAAGGC_UNKNOWN, GOBP_REGULATION_OF_WOUND_HEALING, TGCGCANK_UNKNOWN, GAANYNYGACNY_UNKNOWN, GOBP_POSITIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT, FOXO1_01, GOBP_POSITIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING, FOXD3_01, GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION
GO Biological Process (10): positive regulation of metabolic process (GO:0009893), positive regulation of cell-cell adhesion (GO:0022409), biomineral tissue development (GO:0031214), killing of cells of another organism (GO:0031640), positive regulation of vascular wound healing (GO:0035470), defense response to bacterium (GO:0042742), defense response to fungus (GO:0050832), positive regulation of wound healing (GO:0090303), positive regulation of substrate adhesion-dependent cell spreading (GO:1900026), positive regulation of wound healing, spreading of epidermal cells (GO:1903691)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (5): extracellular region (GO:0005576), mitochondrion (GO:0005739), endoplasmic reticulum (GO:0005783), endoplasmic reticulum membrane (GO:0005789), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Innate Immune System | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| positive regulation of wound healing | 2 |
| defense response | 2 |
| cellular anatomical structure | 2 |
| cytoplasm | 2 |
| intracellular membrane-bounded organelle | 2 |
| metabolic process | 1 |
| regulation of metabolic process | 1 |
| positive regulation of cellular process | 1 |
| regulation of cell-cell adhesion | 1 |
| positive regulation of cell adhesion | 1 |
| cell-cell adhesion | 1 |
| tissue development | 1 |
| animal organ development | 1 |
| cell killing | 1 |
| disruption of cell in another organism | 1 |
| positive regulation of angiogenesis | 1 |
| vascular wound healing | 1 |
| regulation of vascular wound healing | 1 |
| response to bacterium | 1 |
| response to fungus | 1 |
| wound healing | 1 |
| regulation of wound healing | 1 |
| positive regulation of response to wounding | 1 |
| positive regulation of cell-substrate adhesion | 1 |
| substrate adhesion-dependent cell spreading | 1 |
| regulation of substrate adhesion-dependent cell spreading | 1 |
| positive regulation of cell migration | 1 |
| wound healing, spreading of epidermal cells | 1 |
| regulation of wound healing, spreading of epidermal cells | 1 |
| binding | 1 |
| endomembrane system | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
Protein interactions and networks
STRING
374 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| HTN1 | STATH | P02808 | 991 |
| HTN1 | MUC7 | Q8TAX7 | 919 |
| HTN1 | MUC5B | Q9HC84 | 851 |
| HTN1 | PDGFRB | P09619 | 757 |
| HTN1 | CST4 | P01036 | 737 |
| HTN1 | ALB | P02768 | 583 |
| HTN1 | PRPF3 | O43395 | 538 |
| HTN1 | LTF | P02788 | 526 |
| HTN1 | SMR3B | P02814 | 501 |
| HTN1 | CAMP | P49913 | 480 |
| HTN1 | PRR4 | Q16378 | 442 |
| HTN1 | PNRC1 | Q12796 | 437 |
| HTN1 | CSN1S1 | P47710 | 433 |
| HTN1 | TMEM186 | Q96B77 | 432 |
| HTN1 | MUC1 | P13931 | 432 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HTN1 | MUC7 | psi-mi:“MI:0915”(physical association) | 0.510 |
| GPR107 | JTB | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (7): HTN1 (Affinity Capture-MS), HTN1 (Co-purification), HTN1 (Affinity Capture-MS), HTN1 (Affinity Capture-MS), HTN1 (Co-fractionation), HTN1 (Co-fractionation), HTN1 (Proximity Label-MS)
ESM2 similar proteins: A0A0N7FMT9, A8Y3N1, B3SVF0, C5J897, C6KGD8, G1FE62, H2A0M6, H2A0N0, H2A0P1, O08633, O52055, P02808, P07185, P08825, P08826, P08827, P08828, P08829, P0C0U2, P0C0U3, P0DME3, P0DMF8, P13424, P13425, P13426, P13531, P15515, P27781, P34300, P34301, P34407, P34625, P43513, P43514, P43516, P43517, P50438, P50602, P83360, P86960
Diamond homologs: P02808, P15515, P15516, P34084
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
7 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 5 |
| Likely benign | 0 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
562 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:70053058:TTATA:T | acceptor_loss | 1.0000 |
| 4:70053059:TATA:T | acceptor_loss | 1.0000 |
| 4:70053061:TA:T | acceptor_loss | 1.0000 |
| 4:70053062:A:AG | acceptor_gain | 1.0000 |
| 4:70053062:A:T | acceptor_loss | 1.0000 |
| 4:70053063:G:A | acceptor_loss | 1.0000 |
| 4:70053063:G:GG | acceptor_gain | 1.0000 |
| 4:70053124:GATT:G | donor_gain | 1.0000 |
| 4:70053125:ATT:A | donor_gain | 1.0000 |
| 4:70053126:TT:T | donor_gain | 1.0000 |
| 4:70053128:G:GG | donor_gain | 1.0000 |
| 4:70054451:G:GG | donor_gain | 1.0000 |
| 4:70050491:AAAAG:A | donor_loss | 0.9900 |
| 4:70050492:AAAG:A | donor_gain | 0.9900 |
| 4:70050493:AAGGT:A | donor_loss | 0.9900 |
| 4:70050494:AGGTA:A | donor_loss | 0.9900 |
| 4:70050495:GGT:G | donor_loss | 0.9900 |
| 4:70050496:G:GA | donor_loss | 0.9900 |
| 4:70050497:T:A | donor_loss | 0.9900 |
| 4:70053060:ATAG:A | acceptor_gain | 0.9900 |
| 4:70053062:AG:A | acceptor_gain | 0.9900 |
| 4:70053063:GG:G | acceptor_gain | 0.9900 |
| 4:70053123:TGATT:T | donor_gain | 0.9900 |
| 4:70053124:GATTG:G | donor_gain | 0.9900 |
| 4:70053127:TGTA:T | donor_loss | 0.9900 |
| 4:70053128:GTAAG:G | donor_loss | 0.9900 |
| 4:70053129:T:A | donor_loss | 0.9900 |
| 4:70053130:A:AG | donor_loss | 0.9900 |
| 4:70053131:A:AT | donor_loss | 0.9900 |
| 4:70053132:G:T | donor_loss | 0.9900 |
AlphaMissense
378 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:70053096:C:A | A7D | 0.911 |
| 4:70053108:C:A | A11D | 0.866 |
| 4:70053111:T:C | L12P | 0.832 |
| 4:70053111:T:A | L12H | 0.812 |
| 4:70053102:T:A | V9D | 0.807 |
| 4:70055522:T:C | F43L | 0.806 |
| 4:70055524:T:A | F43L | 0.806 |
| 4:70055524:T:G | F43L | 0.806 |
| 4:70053111:T:G | L12R | 0.801 |
| 4:70053090:T:A | V5D | 0.785 |
| 4:70054445:T:C | F33L | 0.776 |
| 4:70054447:C:A | F33L | 0.776 |
| 4:70054447:C:G | F33L | 0.776 |
| 4:70053092:T:C | F6L | 0.770 |
| 4:70053094:T:A | F6L | 0.770 |
| 4:70053094:T:G | F6L | 0.770 |
| 4:70053114:T:G | M13R | 0.717 |
| 4:70053114:T:A | M13K | 0.712 |
| 4:70053083:T:C | F3L | 0.704 |
| 4:70053085:T:A | F3L | 0.704 |
| 4:70053085:T:G | F3L | 0.704 |
| 4:70053124:G:A | M16I | 0.674 |
| 4:70053124:G:C | M16I | 0.674 |
| 4:70053124:G:T | M16I | 0.674 |
| 4:70053107:G:C | A11P | 0.653 |
| 4:70053082:G:C | K2N | 0.613 |
| 4:70053082:G:T | K2N | 0.613 |
| 4:70053095:G:C | A7P | 0.591 |
dbSNP variants (sampled 300 via entrez): RS1000850181 (4:70057930 A>G), RS1000850574 (4:70051957 T>C), RS10008606 (4:70054491 C>A,T), RS1001970723 (4:70049506 T>C), RS10019826 (4:70056347 G>A,T), RS1002022932 (4:70049239 A>G), RS1002679540 (4:70051677 A>G,T), RS1002785803 (4:70057226 G>A), RS1003035460 (4:70051885 T>C), RS1003634044 (4:70050761 T>A,C), RS1003790797 (4:70055927 C>A,T), RS1003843177 (4:70058343 G>T), RS1004845592 (4:70056850 C>G,T), RS1005829988 (4:70048938 A>G), RS1005882498 (4:70048677 T>A)
Disease associations
OMIM: gene MIM:142701 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006904_12 | Cerebral amyloid deposition (PET imaging) | 6.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007707 | cerebral amyloid deposition measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | decreases expression | 1 |
| Mercury | increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.